A Safety and Effectiveness Study of Acetaminophen (4000 mg/Day) and Naproxen (750 mg/Day) in the Treatment of Osteoarthritis of the Hip or Knee

NCT00240773 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

581

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Hip
Osteoarthritis, Knee

Interventions

DRUG: acetaminophen
DRUG: naproxen
DRUG: acetaminophen
DRUG: naproxen

Sponsor

Johnson & Johnson Consumer and Personal Products Worldwide

Collaborators

[object Object]